Danish Pharmacovigilance Update, 20 December 2012

In this issue of Danish Pharmacovigilance Update:

• The Danish Health and Medicines Authority encourages doctors to be aware of suspected long-term adverse reactions from the use of SSRIs in children and adolescents (front page)
• New recommendations for spray application of the tissue adhesive Evicel® (p 2)
• Please report any suspected excessive use or abuse of medicinal products to the Danish Health and Medicines Authority (p 3)
• Reminder of the risk of renal impairment in association with the use of allopurinol (Allopurinol "DAK" and others) (p 4)
• Gathering knowledge of adverse reactions from the use of biological drugs in children (p 5)
• A new report compares adverse reaction reports from medicine users and relatives with reports from healthcare professionals (p 5)
• Danish Medicines Act available on our website (p 6)